rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2006-12-13
|
pubmed:abstractText |
The posttransplant period following hematopoietic stem cell transplantation (HSCT) is potentially high risk for developing survival-compromising complications, many of which are known to be under the control of immunogenetic factors. Given the dual role of human leukocyte antigen (HLA)-E molecules in innate and adaptive immune processes, we analyzed the impact of HLA-E polymorphism in genoidentical HSCT setting.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0041-1337
|
pubmed:author |
pubmed-author:BleuxHélèneH,
pubmed-author:BoukouaciWahidW,
pubmed-author:BrunManuelM,
pubmed-author:BussonMarcM,
pubmed-author:CharronDominiqueD,
pubmed-author:FortierCatherineC,
pubmed-author:GluckmanElianeE,
pubmed-author:HaddadYacineY,
pubmed-author:KrishnamoorthyRajagopalR,
pubmed-author:RochaVandersonV,
pubmed-author:SociéGérardG,
pubmed-author:TamouzaRyadR,
pubmed-author:ToubertAntoineA
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
82
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1436-40
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17164714-Acute Disease,
pubmed-meshheading:17164714-Adolescent,
pubmed-meshheading:17164714-Adult,
pubmed-meshheading:17164714-Alleles,
pubmed-meshheading:17164714-Child,
pubmed-meshheading:17164714-Child, Preschool,
pubmed-meshheading:17164714-Female,
pubmed-meshheading:17164714-Genotype,
pubmed-meshheading:17164714-Graft vs Host Disease,
pubmed-meshheading:17164714-HLA Antigens,
pubmed-meshheading:17164714-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:17164714-Histocompatibility Antigens Class I,
pubmed-meshheading:17164714-Homozygote,
pubmed-meshheading:17164714-Humans,
pubmed-meshheading:17164714-Male,
pubmed-meshheading:17164714-Middle Aged,
pubmed-meshheading:17164714-Siblings
|
pubmed:year |
2006
|
pubmed:articleTitle |
Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation.
|
pubmed:affiliation |
Assistance publique- Hôpitaux de Paris/Groupement Hôspitalier et Universitaire Nord, Institut Universitaire d'Hématologie, et Institut National de la Santé et de la Recherche Médicale U662, Hôpital Saint-Louis, Paris, France. tamouza@histo.chu-stlouis.fr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|